Oscar Lin

Oscar Lin

Auto-generated profile, based on publicly available information

Oscar Lin

Memorial Sloan Kettering Cancer Center

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 August 2016 in Archives of Pathology & Laboratory Medicine
Verified
Journal Article
Closed access
MZMing Zhang
Ming Zhang
OLOscar Lin
Oscar Lin
Context.—: Fine-needle aspiration of thyroid nodules is a reliable diagnostic method to determine the nature of thyroid nodules. Nonetheless, indeterminate cytology diagnoses remain a diagnostic challenge. The development of multiplex molecular techniques and the identification of genetic alterations associated with different follicular cell–derived cancers in the thyroid have led to the introduction of several commercially available tests. Objective.—: To summarize the most common commercially available molecular testing in thyroid cancer, focusing on the technical features and test performance validation. Data Sources.—: Peer-reviewed original articles, review articles, and published conference abstracts were reviewed to analyze the advantages and limitations of the most common tests used in the evaluation of thyroid needle aspirations. Conclusions.—: The most common tests available include the Afirma Gene Expression Classifier, ThyGenX, and ThyroSeq. The excellent negative predictive value (NPV) of the Afirma test allows it to be used as a “rule out” test. ThyGenX analyzes a panel of DNA mutations and RNA translocation fusion markers to assess the risk of malignancy with good NPV and positive predictive value. ThyroSeq is a next-generation sequencing–based gene mutation and fusion test that has been reported to have the best NPV and positive predictive value combined, suggesting that it can be used as a “rule in” and “rule out” test. Molecular testing of cytology specimens from thyroid nodules has the potential to play a major role in the evaluation of indeterminate thyroid lesions.

1 December 2003 in Laboratory Investigation
Verified
Journal Article
Closed access
PDF file
OLOscar Lin
Oscar Lin
MCMarina Cardillo
Marina Cardillo
GDGuido Dalbagni
Guido Dalbagni
ILIrina Linkov
Irina Linkov
BHBrian Hutchinson
Brian Hutchinson
VRVictor E Reuter
Victor E Reuter

25 March 2018 in Diagnostic Cytopathology
Verified
Journal Article
Closed access
PDF file
OLOscar Lin
Oscar Lin
DRDorota Rudomina
Dorota Rudomina
RFRusmir Feratovic
Rusmir Feratovic
SSS. Joseph Sirintrapun
S. Joseph Sirintrapun

3 December 2023 in Journal of the American Society of Cytopathology
Verified
Journal Article
Closed access
DKDavid Kim
David Kim
KSKaitlin E. Sundling
Kaitlin E. Sundling
RVRenu Virk
Renu Virk
MTMichael J. Thrall
Michael J. Thrall
SASusan Alperstein
Susan Alperstein
ZLZaibo Li
Zaibo Li

1 January 2018 in Journal of the American Society of Cytopathology
Verified
Journal Article
Closed access
OLOscar Lin
Oscar Lin

17 May 2023 in Journal of Pathology Informatics
Verified
Journal Article
Open access
OAOrly Ardon
Orly Ardon
EKEric Klein
Eric Klein
AMAllyne Manzo
Allyne Manzo
LCLorraine Corsale
Lorraine Corsale
CEChristine England
Christine England
MHMatthew G. Hanna
Matthew G. Hanna
Whole slide imaging is revolutionizing the field of pathology and is currently being used for clinical, educational, and research initiatives by an increasing number of institutions. Pathology departments have distinct needs for digital pathology systems, yet the cost of digital workflows is cited as a major barrier for widespread adoption by many organizations. Memorial Sloan Kettering Cancer Center (MSK) is an early adopter of whole slide imaging with incremental investments in resources that started more than 15 years ago. This experience and the large-scale scan operations led to the identification of required framework components of digital pathology operations. The cost of these components for the 2021 digital pathology operations at MSK were studied and calculated to enable an understanding of the operation and benchmark the accompanying costs.